Elanco Animal Health Reports Second Quarter Results, Including Strong EPS and Gross Margin Improvement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Elanco Animal Health (ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
August 13, 2019 8:22 AM EDTElanco Animal Health (NYSE: ELAN) Says Postponing Dividend for Financial Flexibility - Bloomberg, Citing Call
Elanco Animal Health (ELAN) Tops Q2 EPS by 2c, Updates FY Guidance
August 13, 2019 6:37 AM EDTElanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $781.6 million versus the consensus estimate of $782.88 million.
GUIDANCE:
Elanco Animal Health sees FY2019 EPS of $1.04-$1.10, versus the... More
